Retrograde transport of acidic fibroblast growth factor as a part of the growth factor signaling

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 4, 1996, Pages 201-207

  Wiȩdłocha, Antoni ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acidic fibroblast growth factor (aFGF); Cellular membranes; Transport of aFGF; Tyrosine kinase

Indexed keywords

DIPHTHERIA TOXIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; CELL NUCLEUS; DNA REPLICATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DIVISION; CELL NUCLEUS; DIPHTHERIA TOXIN; DNA REPLICATION; FIBROBLAST GROWTH FACTOR 1; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN ISOPRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 0030346223     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. ACLAND P., DIXON M., PETERS G. and DICKSON C. (1990): Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature, 343, 662-665.
2. 1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J., 9, 1511-1517.
3. BASILICO C. and MOSCATELLI D. (1992): The FGF family of growth factors and oncogenes. Adv. Cancer Res., 59, 115-165.
4. 1 transition. Proc. Natl. Acad. Sci. USA, 84, 6770-6774.
5. BOYER B. and THIERY J. P. (1993): Cyclic AMP distinguishes between two functions of acidic FGF in a rat blader carcinoma cell line. J. Cell Biol., 120, 767-776.
6. BUGLER B., AMALRIC F. and PRATS H. (1991): Alternative Initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol., 1, 573-577.
7. BURGESS W. H. and MACIAG T. (1989): The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58, 576-606.
8. BURGESS W. H., SHAHEEN A. M., RAVERA M., JAYE M., DONOHUE P. J. and WINKLES J. A. (1990): Possible dissociation of the heparin-binding and mitogenic activites of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activites by site-directed mutagenesis of a single lysine residue. J. Cell Biol., 111, 2129-2138.
9. CAO Y., EKSTROM M. and PETTERSSON R. F. (1993): Characterisation of the nuclear translocation of acidic fibroblast growth factor. J. Cell Sci., 104, 77-87.
10. CHELLAIAH A. T., MCEWEN D. G., WERNER S., XU J. and ORNITZ D. M. (1994): Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF1. J. Biol. Chem., 269, 11620-11627.
11. CLARKE S. (1992): Protein isoprenylation and methylation at carboxy-terminal cysteine residues. Annu. Rev. Biochem., 61, 355-386.
12. ENDICOTT J. A. and LING V. (1989): The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58, 137-171.
13. FALNES P. Ø., WIȨDŁOCHA A., RAPAK A. and OLSNES S. (1995): Farnesylation of CaaX-tagged diphtheria toxin A-fagment as a measure of transfer to the cytosol. Biochemistry, 34, 11152-11159.
14. FOLKMAN J. Y. and SHING Y. (1992): Angiogenesis. J. Biol. Chem., 267, 10931-10934.
15. FRIEDMAN S., ZHAN X. and MACIAG T. (1994): Mutagenesis of the nuclear location sequence in FGF-1 alters protein stability but not mitogenic activity. Biochem. Biophys. Res. Commun., 198, 1203-1208.
16. FRIESEL R., BURGESS W. H. and MACIAG T. (1989): Heparin-binding growth factor-1 stimulates tyrosine phosphorylation in NIH3T3 cells. Mol. Cell. Biol., 9, 1857-1865.
17. FRIESEL E. and MACIAG T. (1995): Molecular mechanism of angiogenesis: fibroblast growth factor signal transduction. FASEB J., 9, 919-925.
18. GLOMSET J. A., GELB M. H. and FARNSWORTH C. C. (1990): Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem. Sci., 15, 139-142.
19. HOU J., KAN M., MCKEEHAN K., MCBRIDE G., ADAMS P. and MCKEEHAN W. L. (1991): Fibroblast growth factor receptors from liver vary in three structural domains. Science, 251, 665-668.
20. IMAMURA T., ENGLEKA K., ZHAN X., TOKITA Y., FOROUGH R., ROEDER D., JACKSON A., MAIER J. A. M., HLA T. and MACIAG T. (1990): Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science, 249, 1567-1570.
21. IMAMURA T., OKA S., TAHANASHI T. and OKITA Y. (1994): Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp. Cell Res., 215, 363-372.
22. IMAMURA T., TOKITA Y. and MITSUI Y. J. (1992): Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis. J. Biol. Chem., 267, 5676-5679.
23. JACKSON A., TARANTINI F., GAMBLE S., FRIEDMAN S. and MACIAG T. (1995): Release of fibroblast growth factor-1 from NIH3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem., 270, 33-36.
24. JAYE M., HOWK R., BURGES W., RICCA G. A., CHIU M. I., RAVERA M. W., O'BRAIEN W. S., MODI S. W., MACIAG T. and DROHAN W. N. (1986): Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. Science, 233, 541-545.
25. JAYE M., LYALL R. M., MUDD R., SCHLESSINGER J. and SARWER N. (1988): Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J., 7, 963-969.
26. JOHNSON D. E., and WILLIAMS L. T. (1993): Structural and functional diversity in the FGF receptor multigene family of growth factors and oncogenes. Adv. Cancer Res., 60, 1-41.
27. JOUANNEAU J., GAVRILOVIC J., CRUELLE D., JAYE M., MOENS G., CARUELLE J. P. and THIERY J. P. (1991): Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA, 88, 2893-2897.
28. KAVANAUGH W. M. and WILLIAMS L. T. (1994): An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science, 266, 1862-1865.
29. KIEFER P., ACLAND P., PAPPIN D., PETERS G. and DICKSON C. (1994): Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J., 13, 4126-4136.
30. KIEFER P. and DICKSON C. (1995): Nucleolar association of fibroblast growth factor 3 via specific sequence motive has inhibitory effect on cell growth. Mol. Cell. Biol., 15, 4364-4374.
31. KIMURA H. (1994): Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. USA, 90, 2165-2169.
32. KLAGSBURN M. and D'AMORE P. A. (1991): Regulators of angiogenesis. Annu. Rev. Physiol., 53, 217-239.
33. LUTZ R. J., TRUJILLO M. A., DENHAM K., WENGER L. and SINENSKY M. (1992): Nucleoplasmic localization of prelamin A: implication for prenylation-dependent lamin A assembly into nuclear lamina. Proc. Natl. Acad. Sci. USA, 88, 3000-3004.
34. MASON I. J. (1994): The ins and cuts of fibroblast growth factors. Cell, 78, 547-552.
35. MCGRATH J. P. and VARSHAVSKY A. (1989): The yeast STE6 gene encodes a omologue of the mammalian multidrug resistence P-glycoprotein. Nature, 340, 400-404.
36. MCLESKEY S. W., DING I. Y. F., LIPPMAN M. E. and KERN F. G. (1994): MDA-MB-134 brest carcinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res., 54, 523-530.
37. MOROIANU J. and RIORDAN J. F. (1994): Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. USA, 90, 1677-1681.
38. NABEL E. G., YANG Z. Y., PLAUTZ G., FOROUGH R., ZAHN X., HAUDENSCHILD C. C., MACIAG T. and NABEL G. J. (1993): Recombinant fibroblast growth factor-1 promotes intymal hyperplasia and angiogenesis in arteries in vivo. Nature, 362, 844-846.
39. NAGLICH J. G., METHERALL J. E., RUSSELL D. W. and EIDELS L. (1992): Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell, 69, 1051-1061.
40. NEUFELD G., MITCHELL R., PONTE P. and GOSPODAROWICZ D. (1988): Expression of human fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth. J. Cell Biol., 106, 1385-1394.
41. NURCOMBE V., FORD M. D., WILDSCHUD J. A. and BARTLET P. F. (1993): Developmental regulation of neuronal response to FGF-1 and FGF-2 by heparan sulfate proteoglycan. Science, 260, 103-106.
42. OLSNES S., MOSKAUG J. Ø., STENMARK H. and SANDVIG K. (1988): Diphtheria toxin entry: protein translocation in the reverse direction. Trends Biochem. Sci., 13, 348-351.
43. OLSNES S. and SANDVIG K. (1988): How protein toxins enter and kill cells. In Frankel A. E. (ed.): Immunotoxins. Martinus Nijhoff Publishing, Boston, pp. 39-73.
44. OLWIN B. B. and RAPRAEGER A. (1992): Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulfate. J. Cell Biol. 118, 631-639.
45. PAPPENHEIMER A. M. JR. (1977): Diphtheria toxin. Annu. Rev. Biochem., 46, 69-94.
46. POWELL P. P. and KLAGSBRUN M. (1991): Three forms of rat basic fibroblast growth actor are made from a single mRNA and localise to the nucleus. J. Cell .Physiol., 148, 202-210.
47. PRUDOWSKI I., SAVION N., ZHAN X., FRIESEL R., XU J., MCKEEHAN W. L. and MACIAG T. (1994): Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem., 269, 31720-31724.
48. ROELSE J., GROMME M., MOMBURG F., HAMMERLING G. and NEEFJEES J. (1994:) Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med., 180, 1591-1597.
49. RUBARTELLI A. and SITIA R. (1996): Entry of exogenous polypeptides into the nucleus of living cells: facts and speculation. Trends Cell Biol., 5, 409-412.
50. SANO H., FOROUGH R. M., MAIER A. J., CASE J. P., JACKSON A., ENGLEKA K., MACIAG T. and WILDER L. R. J. (1990): Delection of high levels of heparin binding growth factor (acidic fibroblast growth factor) in inflammatory arthritic joints. J. Cell Biol., 10, 1417-1426.
51. SHARMA R. C., INOUE S., ROITELMAN J., SCHIMKE R. T. and SIMONI R. D. (1992): Peptide transport by the multidrug resistance pump. J. Biol. Chem., 267, 5731-5734.
52. TAMM I., KIKUCHI T. and ZYCHLINSKI A. (1991): Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c3T3 murine fibroblast. Proc. Natl. Acad. Sci. USA, 88, 3372-3376.
53. TANAKA A., MIYAMOTO K., MINAMINO N., TAKEDA M., SATO B., MATSUO H. and MATSUMOTO K. (1992): Cloning and characterization of an androgen induced growth factor essential for androgen-dependent growth of mouse mammary tumor cells. Proc. Natl. Acad. Sci. USA, 89, 8928-8932.
54. WIȨDŁOCHA A., FALNES P. Ø., MADSHUS I. H., SANDVIG K. and OLSNES S. (1994): Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell, 76, 1039-1051.
55. WIȨDŁOCHA A., FALNES P. Ø., RAPAK A., KLINGENBERG O., MUNOZ, R. and OLSNES S. (1995): Translocation to cytosol of exogenous, caax-tagged acidic fibroblast growth factor. J. Biol. Chem., 270, 30680-30685.
56. WIȨDŁOCHA A., FALNES P. Ø., RAPAK A., MUNOZ R., KLINGENBERG O. and OLSNES S. (1996): Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization. Mol. Cell. Biol., 16, 270-280.
57. WIȨDŁOCHA A., MADSHUS I. H., MACH H., MIDDAUGH C. R. and OLSNES S. (1992): Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J., 11, 4835-4842.
58. XU J., NAKAHARA M., CRABB J. W., SHI E., MATUO Y., FRASER M., KAN M., HOU J. and MCKEEHAN W. L. (1992:) Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem., 267, 17792-17803.
59. YAN G., FUKABORI Y., MCBRIDE G., NIKOLARPOLOUS S. and MCKEEHAN W. L. (1993): Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-EGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol., 13, 4513-4522.
60. ZHAN X., HU X., FRIEDMAN S. and MACIAG T. (1992): Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH3T3 cells. Biochem. Biophys. Res. Commun., 188, 982-991.
61. ZHAN X., HU X., FRIESEL R. and MACIAG T. (1993): Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem., 268, 9611-9620.
62. ZHAN X., HU X., HAMPTON B., BURGESS W. H., FRIESEL R. and MACIAG T. (1993): Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G, phase of Balb/c3T3 cell cycle. J. Biol. Chem., 268, 24427-24431.
63. ZHAN X., PLOURDE C., HU X., FRIESEL R. and MACIAG T. (1994): Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-SRC and cortactin. J. Biol. Chem., 269, 20221-20224.
64. ZUNIGA MEIJER BORJA A. Z., MEJERS C. and ZELLER R. (1992): Expression of alternatively spliced bFGF first coding exons and antisense RNAs during chicken embryogenesis. Dev. Biol., 157, 110-118.